| http://www.w3.org/ns/prov#value | - r, prostate cancer or renal cell cancer.Another aspect of the invention is affinity reagents capable of specific binding to the proteins of the invention or fragments thereof, for example affinity reagents which contain or are conjugated to a detectable label or contain or are conjugated to a therapeutic moiety such as a cytotoxic moiety.
|
